肝硬化
酒精性肝病
肝病
肝癌
脂肪肝
肝再生
癌症研究
慢性肝病
纤维化
医学
PDZ域
生物
疾病
肝细胞癌
病理
内科学
再生(生物学)
细胞生物学
作者
Di Chen,Hongmei Zhang,Xin Zhang,Xia Sun,Qiaohong Qin,Ying Hou,Min Jia,Yulong Chen
标识
DOI:10.1016/j.biopha.2022.113166
摘要
The prevalence of liver disease has been increasing worldwide. Moreover, the burden of end-stage liver disease, including cirrhosis and liver cancer, is high because of high mortality and suboptimal treatment. The pathological process of liver disease includes steatosis, hepatocyte death, and fibrosis, which ultimately lead to cirrhosis and liver cancer. Clinical and preclinical evidence indicates that non-neoplastic liver diseases, particularly cirrhosis, are major risk factors for liver cancer, although the mechanism underlying this association remains unclear. Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are transcriptional activators that regulate organ size and cancer development. YAP and TAZ play important roles in liver development, regeneration, and homeostasis. Abnormal YAP and TAZ levels have also been implicated in non-neoplastic liver diseases (e.g., non-alcoholic fatty liver disease, alcoholic liver disease, liver injury, and liver fibrosis). Here, we review recent findings on the roles of YAP and TAZ in non-neoplastic liver diseases and discuss directions for future research. This review provides a basis for the study of non-neoplastic liver diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI